Overview and Scope
Stem cells refer to cells which have the rare capacity to renew themselves and develop into specialized cell types. They act like the building blocks of all living things. Stem cell assay is developed for studying human stem cell growth to analyze the biological activities of stem cells in a controlled environment.
Sizing and Forecast
The stem cell assay market size has grown exponentially in recent years. It will grow from <b>$1.94 billion in 2023 to $2.35 billion in 2024 at a compound annual growth rate (CAGR) of 21.2%. </b> The growth in the historic period can be attributed to biotechnology advancements, drug discovery and development, regenerative medicine research, disease modeling, public and private investment.
The stem cell assay market size is expected to see exponential growth in the next few years. It will grow to <b>$5.16 billion in 2028 at a compound annual growth rate (CAGR) of 21.7%. </b> The growth in the forecast period can be attributed to personalized medicine and cell therapy, organoid and tissue engineering, ai and machine learning, emerging technologies, regulatory and ethical considerations:. Major trends in the forecast period include 3d cell culture models, high-throughput screening, personalized medicine, crispr-cas9 and genome editing, drug safety and toxicity testing.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Segmentation & Regional Insights
The stem cell assay market covered in this report is segmented –
1) By Type: Cell Viability And Toxicity Assays, Cell Apoptosis Assays, Cell Function Assays, Cell Identification Assays, Isolation And Purification Assays, Cell Differentiation Assay, Other Types
2) By Product: Instruments, Detection kit
3) By Application: Regenerative Medicine And Therapy Development, Drug Discovery And Development, Clinical Research
4) By End User: Government Research Institutes, Private Research Institutes, Industry Research
<b>North America</b> was the largest region in the stem cell assay market share in 2023. <b>Asia-Pacific</b> is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell assay market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7701&type=smp
Major Driver Impacting Market Growth
The high prevalence of chronic diseases is expected to propel the growth of the stem cell assay market going forward. Chronic disease refers to an ailment or illness that often lasts for three months or longer and has the potential to worsen over time. Stem cells have the potential to treat a wide range of diseases, including chronic diseases. They help in the development of new antibodies and specialized cells that help to cure chronic diseases such as cancer. For instance, according to the Australian Bureau of Statistics, an independent statuary agency of the Australian government, in 2021, nearly 46.6% of Australians of all ages had one or more chronic diseases, and nearly one in five that is 20.7% had two or more chronic diseases. Therefore, the increase in the prevalence of chronic diseases is driving the growth of the stem cell assay market.
Key Industry Players
Major companies operating in the stem cell assay market include <b> Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., PerkinElmer Inc., Agilent Technologies Inc., Promega Corporation, Cell Biolabs Inc., Miltenyi Biotec GmbH, STEMCELL Technologies Inc., Bio-Techne Corporation, Charles River Laboratories International Inc., Hemogenix Inc., Lonza Group AG, Takara Bio Inc., Creative Bioarray, AAT Bioquest Inc., BPS Bioscience Inc., Enzo Life Sciences Inc., PromoCell GmbH, Biotium Inc., Geno Technology Inc., Abcam plc, ReachBio Research Labs. Inc., Sartorius AG, Eppendorf AG, Corning Incorporated, Smith & Nephew plc, MEDIPOST Co. Ltd., Anterogen Co. Ltd., Corestemchemon Inc., Pharmicell Inc., NuVasive Inc., RTI Surgical Holdings Inc., AlloSource LifeSource Services Inc., JCR Pharmaceuticals Co. Ltd. </b>
The stem cell assay market report table of contents includes:
1. Executive Summary
2. Stem Cell Assay Market Characteristics
3. Stem Cell Assay Market Trends And Strategies
4. Stem Cell Assay Market – Macro Economic Scenario
5. Global Stem Cell Assay Market Size and Growth
.
.
.
26. South America Stem Cell Assay Market
28. Middle East Stem Cell Assay Market
29. Africa Stem Cell Assay Market
30. Stem Cell Assay Market Competitive Landscape And Company Profiles
Top Major Players:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Becton Dickinson and Company
- Bio-Rad Laboratories In
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
